The conservative Wall Street Journal continues to go after FDA CBER Director Vinay Prasad. WSJ still doesn’t like CBER Director Vinay Prasad What’s going on? Here’s a new piece from the paper’s editorial board: Dr. Prasad, the FDA’s Grim Reaper. That’s a strong headline. The piece is also critical of RFK Jr. Earlier Prasad temporarily […]
The post Weekly reads: WSJ vs. Prasad, MUSE cells, Lyme disease, longevity signal vs. noise appeared first on The Niche.